Max Super Speciality Hospital Saket Launches Exclusive Multi-Specialty OPD Services in Patna

 

Patna, 2nd December 2023: Leading healthcare providers in North India, Max Super Specialty Hospital Saket, New Delhi, today announced the launch of its exclusive multi-specialty OPD services in partnership with the city-based Buddha Cancer Centre.

The OPD services were launched in the presence of Dr. Rayaz Ahmed, Senior Director, Bone Marrow Transplant, Dr. Nikhil Agrawal, Director, Surgical Oncology from Max Super Speciality Hospital, Saket and Dr. Tushar Aditya Narain, Senior Consultant, Uro-Oncology and Robotic Surgery at Max Smart Super Speciality Hospital Saket and Dr Arvind Kumar - Director - Budha Cancer Centre, Patna who will be available for primary consultations at Buddha Cancer CentreRupaspur, Bailey Road, Patna on specific days of every month for OPD according to their schedule. 

Dr. Rayaz Ahmed will be available on the 3rd Wednesday of every month from 09:00 AM to 02:00 PM, Dr. Nikhil Agrawal, will be available on the 2nd Thursday of every month from 10:00 AM to 02:00 PM and Dr. Tushar Aditya Narain, will be present on the last Saturday of every month from 11:00 AM to 03:00 PM.

Addressing the press conference, Dr. Rayaz Ahmed, Senior Director, Bone Marrow Transplant, Max Super Speciality Hospital, Saket, who has performed over 1000 bone marrow transplants till now and a pioneer in the field said, “With advancements made in the field of hematology and stem cell transplantation, bone marrow transplants (BMT) are emerging as the best life savior for potentially fatal disorders. Bone marrow is the soft fatty tissue inside the bones that proliferate into blood cells. The procedure is classified into two types – Allogenic (any donor with tissue match) and Autologous (where stem cells are taken from the same body). During a typical BMT, the damaged or destroyed bone marrow needs to be replaced with healthy ones and the major restricting factor lies in the matching of the donor cells. Recent advancements have eliminated the waiting period for many patients awaiting a BMT on an urgent basis.”

Dr Nikhil Agrawal, Director, Surgical Oncology (GI-HPB), Max Super Speciality Hospital Saket said “As a group gastrointestinal cancer is the most common cancerglobally. Minimally invasive surgeries have numerous advantages for patients in comparison to traditional surgeries including minimal scars, faster recovery, reduced pain, shorter hospital stays, and lesser post-surgery complications. With advanced surgical technologies like Da Vinci robotic-assisted surgeries, we are able to perform these procedures more efficiently with minimal post-operative care and faster recovery. The treatment of GI cancers requires a multidisciplinary approach and advanced surgical skillset.” 

During the launch, Dr Tushar Aditya Narain, Senior Consultant, Uro-Oncology and Robotic Surgery, Max Smart Super Speciality Hospital Saket said “The advantages offered by robotic urological surgery over traditional approach are manifold, owing to the minimally invasive approach, 3-D and highly magnified vision and the movement of the robotic arms replicating the movement of the surgeons’ hands. Robotic technology has transformed a wide range of urological procedures covering the entire spectrum of urologic cancer care. Prostate surgery has been revolutionized, enabling surgeons to precisely remove the whole prostate while preserving surrounding structures and nerves, thereby minimizing the risk of urinary incontinence and erectile dysfunction. For kidney cancer, robotic techniques allow for the complete removal of the affected kidney for large tumors and only the removal of the tumor for smaller masses and preservation of the rest of the kidney, with minimal blood loss and expedited recovery. In bladder surgery, robotics aid in complex reconstructions, creation of neo bladder with intestines after bladder removal. Additionally, robotic-assisted procedures provide effective solutions for conditions such as testicular cancer, penile cancer and adrenal cancer with minimal morbidity.